Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer

被引:1
|
作者
Zong, Hua [1 ]
Zou, Jian-Qiang [1 ]
Huang, Jian-Peng [1 ]
Huang, Shi-Ting [1 ]
机构
[1] Third Peoples Hosp Shenzhen, Dept Gastrointestinal Surg, 29 Bulan Rd, Shenzhen 518000, Guangdong, Peoples R China
关键词
Colorectal cancer; Long noncoding RNA RP5-881L22.5; Tumor immune microenvironment; Biomarker; Therapeutic target; LNCRNA; CELLS;
D O I
10.4251/wjgo.v14.i11.2108
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND The incidence of colorectal cancer in humans is high, and it is in the top five for cancer-related morbidity and mortality. It is one of the main threats to human health. The function of long noncoding RNAs in tumor occurrence and development has gradually gained attention in recent years. In increasing numbers of studies, researchers have demonstrated that it plays an important role in the pathogenesis of colorectal cancer. AIM To find out if long noncoding RNA RP5-881L22.5 played a role in the pathogenesis of colorectal cancer in relation to the tumor microenvironment. METHODS We analyzed the transcriptome data and clinical data in The Cancer Genome Atlas-colon adenocarcinoma. The CIRBERSORT algorithm was applied to evaluate these tumor-infiltrating immune cells in The Cancer Genome Atlas-colon adenocarcinoma cancer tissue samples. Using the "estimate" package in R, we assessed the tumor immune microenvironment. The expression level of RP5-881L22.5 in tumor tissue and adjacent normal tissue samples from 4 pairs of colorectal cancer patients was determined by quantitative reverse transcription PCR. Colorectal cancer cells were tested for invasiveness using a transwell invasion assay after RP5-881L22.5 expression was knocked down. RESULTS The expression of lncRNA RP5-881L22.5 was related to the clinical characteristics of the tumors, and it was negatively related to the infiltration level of immune cells in the tumor microenvironment and the expression of T cell inhibitory receptors. A major function of its coexpressed mRNA was to regulate tumor immunity, such as the immune response. When quantitative reverse transcription PCR was performed on tumor tissues from 4 pairs of colorectal cancer patients, the results showed that RP5-881L22.5 was highly expressed. Subsequently, knocking down the expression of RP5-881L22.5, the invasiveness of colorectal cancer cell lines was reduced, and the apoptosis rate was increased. CONCLUSION RP5-881L22.5 plays a crucial role in the microenvironment of tumors as well as in the pathogenesis of colorectal cancer. The relationship between RP5-881L22.5 and the tumor immune microenvironment deserves further study.
引用
收藏
页码:2108 / 2121
页数:14
相关论文
共 50 条
  • [1] Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer
    Hua Zong
    Jian-Qiang Zou
    Jian-Peng Huang
    Shi-Ting Huang
    [J]. World Journal of Gastrointestinal Oncology, 2022, 14 (11) : 2108 - 2121
  • [2] Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma
    Chen, Xiangjun
    Gao, Guozhen
    Liu, Sha
    Yu, Li
    Yan, Dexiong
    Yao, Xingwei
    Sun, Weijing
    Han, Dezhi
    Dong, Hao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [3] Long noncoding RNA small nucleolar RNA host gene 1 as a potential novel biomarker for intraperitoneal free cancer cells in colorectal cancer
    Wu, Yudi
    Liu, Liang
    He, Fangxun
    Zhang, Yujie
    Jiang, Wei
    Cao, Zhixin
    Xu, Xiangshang
    Gong, Jianping
    [J]. ISCIENCE, 2024, 27 (07)
  • [4] Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma
    D'Aniello, C.
    Pisconti, S.
    Facchini, S.
    Imbimbo, C.
    Cavaliere, C.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (05) : 1169 - 1170
  • [5] Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma
    He, Z. -H.
    Qin, X. -H.
    Zhang, X. -L.
    Yi, J. -W.
    Han, J. -Y.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (01) : 46 - 54
  • [6] Long noncoding RNA: a new contributor and potential therapeutic target in fibrosis
    Jiang, Xiaoying
    Zhang, Fujun
    [J]. EPIGENOMICS, 2017, 9 (09) : 1233 - 1241
  • [7] Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer
    Wang, Liye
    Cho, Kwang Bog
    Li, Yan
    Tao, Gabriel
    Xie, Zuoxu
    Guo, Bin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (22)
  • [8] Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer
    Crea, Francesco
    Watahiki, Akira
    Quagliata, Luca
    Xue, Hui
    Pikor, Larissa
    Parolia, Abhijit
    Wang, Yuwei
    Lin, Dong
    Lam, Wan L.
    Farrar, William L.
    Isogai, Takao
    Morant, Rudolf
    Castori-Eppenberger, Serenella
    Chi, Kim N.
    Wang, Yuzhuo
    Helgason, Cheryl D.
    [J]. ONCOTARGET, 2014, 5 (03) : 764 - 774
  • [9] Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer
    Su, Yin-Jie
    Yu, Jin
    Huang, Ya-Qin
    Yang, Jin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (06) : 13322 - 13338
  • [10] Long non-coding RNA TINCR as potential biomarker and therapeutic target for cancer
    Sharma, Uttam
    Barwal, Tushar Singh
    Malhotra, Akshay
    Pant, Neha
    Vivek
    Dey, Damayanti
    Gautam, Ashima
    Tuli, Hardeep Singh
    Vasquez, Karen M.
    Jain, Aklank
    [J]. LIFE SCIENCES, 2020, 257